HAT01H

· Haus Bioceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HAT01H, covering 2018-11-07 to 2018-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis [Phase 1, Phase 2]